Thiogenesis Therapeutics, Corp. (TSXV:TTI)
Canada · Delayed Price · Currency is CAD 0.6700
-0.0100 (-1.47%)
Oct 22, 2025, 10:49 AM EDT
Thiogenesis Therapeutics Market Cap
Thiogenesis Therapeutics has a market cap or net worth of CAD 34.73 million as of October 23, 2025. Its market cap has decreased by -3.37% in one year.
Market Cap
34.73M
Enterprise Value
32.89M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.67
Market Cap Chart
Since April 13, 2022, Thiogenesis Therapeutics's market cap has increased from 13.96M to 34.73M, an increase of 148.87%. That is a compound annual growth rate of 29.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2025 | 33.18M | 20.15% |
| Dec 31, 2024 | 27.61M | -17.40% |
| Dec 29, 2023 | 33.43M | 48.30% |
| Dec 30, 2022 | 22.54M | 61.52% |
| Apr 13, 2022 | 13.96M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curaleaf Holdings | 3.07B |
| Green Thumb Industries | 2.44B |
| dentalcorp Holdings | 2.18B |
| Trulieve Cannabis | 2.04B |
| Sienna Senior Living | 1.82B |
| Cronos Group | 1.34B |
| Extendicare | 1.29B |
| WELL Health Technologies | 1.24B |